The Board of Directors maintain the ethos of the company, ensuring corporate goals are followed consistently.
Rob is an expert in the fields of molecular modeling and cheminformatics. His previous roles include CEO of Amedis and VP, Europe at CambridgeSoft. His DPhil is in Chemistry from the University of Oxford. Rob is passionate about applying computational methods to help meet medical challenges. He believes drug discovery and design can be streamlined and improved through the use of computational methods, resulting in better drugs being brought to market sooner. Rob is a Fellow of the Royal Society of Chemistry.
Mark was one of the founders of Cresset when the company was formed in 2002. He became CSO in 2013 and heads up our scientific team. He has made fundamental contributions to our underlying scientific approach and to the development of the software. He works hard to extend the scientific base of the company in a way that is consistent with our reputation of rigorous scientific excellence. His team’s current research includes new ways of applying the XED force fields to proteins and improving the handling of water molecules. Mark’s previous experience includes roles at Napp Pharmaceuticals and Merck, Sharpe and Dohme. His PhD is in Chemistry from the University of Cambridge. Mark is a Fellow of the Royal Society of Chemistry and on the Board of the Open Force Field Consortium.
After a DPhil in Chemistry at the University of Oxford, Tim gained experience as a medicinal chemist and a molecular modeler at Peptide Therapeutics and Medivir. Tim was a co-founder of Cresset when the company was formed in 2002 and has been instrumental in developing the easy to use scientific software that characterises Cresset today. As Director of Products Tim is responsible for Cresset’s range of software for computational chemists and medicinal chemists. Tim's commitment to innovative, usable and accessible science is evident in every release.
As Commercial Director David heads up the Sales and Marketing team. Through his global role and direct interactions with people across industry and academia, he is always seeking ways to serve our customers better. His fundamental rule is to listen to the customer in order to discover and understand their needs. David has extensive commercial experience with software and technology solutions in the scientific market. Prior to Cresset, David was responsible for business development and strategic commercial growth, with Symyx Technologies and CambridgeSoft. David has a PhD and BSc in Microbiology from the University of Wales, Cardiff.
After graduating from Newcastle University, Rebecca led the administration and customer relations team at a software company in London. She joined Cresset in 2012, was appointed as Company Secretary in 2017 and COO in 2021. Rebecca has responsibility for administrative, finance, IT and HR functions of the business.
Advises and contributes to the continued growth of the company
David brings a wealth of experience in the life sciences, technology and services sectors, which will complement the existing skills and experiences around the Board table. He currently also serves as Managing Director of SPT Labtech.
The Management Team are responsible for the day-to-day operation of Cressset in line with objectives set by the Board of Directors.
Martin studied medicinal chemistry at the Universities of Huddersfield and Leeds then spent 14 years in the highly dynamic pharmaceutical ‘fee for service’ environment at BioFocus where he supported medicinal chemistry and a diverse range of programs. Martin heads up our Discovery team and thrives on the varied challenges of applying our computational chemistry expertise to a wide range of collaborative work. His innovative and rigorous approach combines excellent science with outstanding customer communication.
After graduating in Biology from the University of Padova, Giovanna spent 20 years at Glaxo/GlaxoWellcome/GSK as a computational chemist, with increasing responsibilities. As a senior computational chemist, she supported a variety of drug discovery programs in the antibacterial and CNS areas, and led target-to-lead CNS programs. More recently, she supported business development as a senior proposal driver at Aptuit. Giovanna joined Cresset in December 2014. She has responsibility for delivering Cresset’s desktop solutions for computational and medicinal chemists.
Ritesh joined Cresset in 2014. Leading the commercial interest for the software and discovery business units in Europe, he is passionate about delivering cutting-edge solutions to help bring new insights and efficiency to our customers discovery challenges. Prior to joining Cresset, Ritesh was responsible for business development at Charnwood Molecular and Johnson Matthey’s Catalysis and Chiral Technologies division. Ritesh received his PhD in Organic Chemistry from the University of Loughborough.
Sue joined Cresset in 2012 and has responsibility for developing and implementing marketing strategy across the software and discovery business units. Prior to joining Cresset Sue was responsible for promotion of laboratory and pharmaceutical equipment globally, most recently as senior marketing associate at Capsugel, a divison of Pfizer.
Nigel joined Cresset in 2013 and leads software development. He has worked on the design and development of Cresset desktop solutions, including the Python API for Flare™. His team works closely with the Cresset scientific team to add new scientific methods to the software, ensuring ease of use and flexible interfaces. Nigel previously developed software for satellite programs and UAV training systems for SELEX SI. He has a BSc Computer Science from Queen Mary, University of London.